Navigation Links
UC San Diego Offers New Certificate for Clinical Trials Administration in Latin America
Date:11/9/2010

LA JOLLA, Calif., Nov. 9, 2010 /PRNewswire/ -- The clinical trials program at UC San Diego Extension, one of the first and most widely recognized educational programs of its kind in the world, is now accepting international students for its new Clinical Trials Administration in Latin America Certificate.

Classes are taught by Spanish-speaking medical faculty with practical, international experience. Medica Sur, one of the most respected physician/research groups in Mexico, is sending the first cohort of students through the program.

"The demand for clinical trials in Latin America is expected to grow tenfold in the next five years," says Dr. Leonel Villa-Caballero, the director of the Latin America clinical trials program. "Our certificate helps clinicians and other health professionals meet this demand for specific expertise in the design and administration of trials that will meet high government standards in the region. We are happy to offer a high-quality program for the growing audience and pharmaceutical industry in need of clinical trial education in Latin America."

Three sections are needed to complete the Clinical Trials Administration in Latin America Certificate. Phase one can be taken online or in-person, which provides networking opportunities with UC San Diego faculty and San Diego industry leaders. Phase two and three are taught fully online. The certificate can be completed in as little as six months.

Pharmaceutical and medical device development has become one of the premier industries of the 21st Century, with Latin America taking an international role in biomedical research and biotechnical development. Critical to the industry are clinical trials, the experiments to evaluate new drugs, medical devices or other interventions on patients in strictly scientifically controlled settings that are required for regulatory authority approval of new therapies.

"Offering a clinical trials program totally in Spanish ensures we are reaching the important Latin America research market in addition to researchers and clinicians in Spain," says Dr. Villa-Caballero.

Today's clinical trials require careful planning and cooperation among a variety of professionals within the pharmaceutical and biotechnical industry, clinical practice, and governmental or industrial agencies who need both specialized expertise and general familiarity with a variety of procedures.

However, before the UC San Diego Extension clinical trials program was developed more than a decade ago, exposure to this knowledge was difficult to acquire and was frequently obtained only through on-the-job experience over a number of years. During the past ten years more than one-thousand professionals -- from such local and national companies as Amilyn, Pfizer, Novartis, Gen-Probe, Biogen Idec, Neurocrine, and Quintiles -- have received clinical trials certificates from UC San Diego Extension.

More information on the Latin America certificate program is available at http://www.extension.ucsd.edu/estudiosclinicos or by calling Saytel Lopez at 858-964-1058.

This news release and any accompanying images can be accessed on the web at: http://ucsdnews.ucsd.edu/newsrel/general/10-29ForClinical.asp

Learn more about UC San Diego. Subscribe to ThisWeek@UCSD: http://email.e-mailnetworks.com/phase2/survey1/survey.htm?cid=fgnvtx

UCSD News on the web at: http://ucsdnews.ucsd.edu Media Contact: Henry DeVries (858) 534-9955 or hdevries@ucsd.edu
'/>"/>

SOURCE University of California San Diego Extension
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. San Diegos Original Biotech Company Celebrates 30th Anniversary With Reunion
2. Amicus Therapeutics Opens Research Facility in San Diego
3. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
4. DermTech and Rady Childrens Hospital-San Diego, Initiate Study to Understand Effects of Vitamin D as a Treatment for Atopic Dermatitis in Children and Young Adults
5. Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs
6. Genetic clock makers at UC San Diego publish their timepiece in Nature
7. San Diego universities, government and industry rally around local Clean-Tech cluster
8. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
9. A Scientific Milestone: Sex of Dolphin at SeaWorld San Diego Determined Prior to Conception
10. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
11. NIH News Confirms Trend in Stem Cell Storage Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
Breaking Biology Technology:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):